Skip to content

RxSight, Inc. RXST Free cash flow

Free cash flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$0
Ocular Therapeutix logo
Ocular TherapeutixOCUL
-$70.66M-51.6%
Precision Optics Corporation logo
Precision Optics CorporationPOCI
-$615.46K+37.7%
Bausch + Lomb logo
Bausch + LombBLCO
-$68M+49.6%
Schering-Plough logo
Schering-PloughSGP

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Calculated from RxSight, Inc.’s reported figures.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s free cash flow?
RxSight, Inc. (RXST) reported free cash flow of -$11.65M in Q1 2026.
How has RxSight, Inc.'s free cash flow changed year-over-year?
RxSight, Inc.'s free cash flow decreased by 23.8% year-over-year, from -$9.41M to -$11.65M.
What is the long-term trend for RxSight, Inc.'s free cash flow?
Over 4 years (2021 to 2025), RxSight, Inc.'s free cash flow has grown at a -19.8% compound annual growth rate (CAGR), from -$46.65M to -$19.34M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.